Mestastop Solutions is a deep-dive biotech start-up focussed on cancer metastasis, which involves the spreading of the tumour, and is responsible for 90% of cancer deaths. Mestastop has developed three proprietary platforms, METAssay®, METSCAN®, and METVivo®, to unravel metastasis drug discovery and predictive diagnostics. The platforms have been validated in both prospective and retrospective clinical studies. Currently, the company is extending the platform into multiple epithelial carcinomas.